These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8529505)

  • 1. Pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM).
    Beck-Nielsen H; Henriksen JE; Vaag A; Hother-Nielsen O
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S13-25. PubMed ID: 8529505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives.
    Beck-Nielsen H; Henriksen JE; Alford F; Hother-Nielson O
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S78-84. PubMed ID: 8894487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
    Reaven GM
    Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity.
    Calles-Escandon J; Jaspan J; Robbins DC
    Diabetes Care; 1989; 12(10):709-14. PubMed ID: 2693010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of insulin secretion in diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Porte D
    Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
    Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
    Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From obesity to type 2 diabetes.
    Scheen AJ
    Acta Clin Belg Suppl; 1992; 14():30-6. PubMed ID: 1604959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the prediabetic state.
    Groop L; Forsblom C; Lehtovirta M
    Am J Hypertens; 1997 Sep; 10(9 Pt 2):172S-180S. PubMed ID: 9324118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretion in obese and non-obese NIDDM.
    Cerasi E; Nesher R; Gadot M; Gross D; Kaiser N
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S27-37. PubMed ID: 8529516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
    Porte D; Kahn SE
    Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus.
    Rossetti L
    Clin Invest Med; 1995 Aug; 18(4):255-60. PubMed ID: 8549010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward an integrated phenotype in pre-NIDDM.
    Bergman RN; Watanabe R; Rebrin K; Ader M; Steil G
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S67-77. PubMed ID: 8894486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, insulin deficiency, and non-insulin-dependent diabetes mellitus.
    Cerasi E
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S37-45. PubMed ID: 1794264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
    Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
    Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell behavior during the prediabetic stage. Part I. Beta-cell pathophysiology.
    Homo-Delarche F
    Diabetes Metab; 1997 Jun; 23(3):181-94. PubMed ID: 9233994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance and pathogenesis of non-insulin-dependent diabetes mellitus (part II)].
    Martinka E; Galajda P; Mokán M
    Vnitr Lek; 1996 Mar; 42(3):200-4. PubMed ID: 8686211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.